The Tasmanian Epilepsy Register - A community-based cohort: Background and methodology for patient recruitment from the Australian national prescription database

Neuroepidemiology

Volumn 29, Issue 3-4, 2008, Pages 255-263

  D'Souza, Wendyl J ^a,b   Fryer, Jayne L ^a   Quinn, Stephen J ^a   Taylor, Bruce V ^c   Ficker, David M ^e   O'Brien, Terence J ^b   Pearce, Neil E ^d   Cook, Mark J ^b  

^a UNIVERSITY OF TASMANIA   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d MASSEY UNIVERSITY   (New Zealand)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Epidemiologic methods; Epidemiology; Epilepsy; Patient recruitment; Prescriptions; Recruitment, neurology

Indexed keywords

CARBAMAZEPINE; ETHOSUXIMIDE; GABAPENTIN; LAMOTRIGINE; METHYLPHENOBARBITAL; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DEMOGRAPHY; DISEASE REGISTRY; EPILEPSY; FEMALE; GENERAL PRACTITIONER; GOVERNMENT; HEALTH INSURANCE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATIENT INFORMATION; PEDIATRICIAN; POSTAL MAIL; PRESCRIPTION; REFERENCE DATABASE; SOCIOECONOMICS; TREATMENT INDICATION;

ADULT; AGE FACTORS; ANTICONVULSANTS; COHORT STUDIES; COMMUNITY HEALTH SERVICES; DATABASES, FACTUAL; EPIDEMIOLOGIC METHODS; EPILEPSY; FEMALE; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SELECTION; POPULATION SURVEILLANCE; PRESCRIPTIONS, DRUG; REFERRAL AND CONSULTATION; REGISTRIES; SOCIOECONOMIC FACTORS; SPECIALTIES, MEDICAL; TASMANIA;

EID: 38849194096     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112859     Document Type: Article

References (42)

1. Placencia M, Suarez J, Crespo F, Sander JWAS, Shorvonl SD, Ellison RH, Cascante SM: A large-scale study of epilepsy in Ecuador: methodological aspects. Neuroepidemiology 1992;11:74-84.
2. Meneghini F, Rocca WA, Grigoletto F, Morgante L, Reggio A, Savettieri G, et al: Door-to-door prevalence survey of neurological diseases in a Sicilian population: background and methods. Neuroepidemiology 1991;10:70-85.
3. Osuntokun BO, Schoenberg BS, Nottidge VA, Adeuja A, Kale O, Adeyefa A, et al: Research protocol, measuring the prevalence of neurological disorders in developing countries. Results of a pilot study in Nigeria. Neuroepidemiology 1982;1:143-153.
4. Schoenberg BS: Clinical neuroepidemiology in developing countries: Neurology with few neurologists. Neuroepidemiology 1982;1:137-142.
5. Sander JWAS, Shorvon SD: Incidence and prevalence studies in epilepsy and their methodological problems: a review. J Neurol Neurosurg Psychiatry 1987;50:829-839.
6. Australian Bureau of Statistics: Population by Age and Sex, Australian States and Territories. Canberra, Australian Bureau of Statistics, June 2003, Rep. No.: Cat. No. 3201.0.
7. Jones G, Ding CH, Hynes KL, Ma D, Glisson M, Cicuttini FM: Knee articular cartilage development in children: a longitudinal study of the effect of gender, growth, Tanner stage and physical activity. Pediatr Res 2003;54:230-236.
8. Department of Health &Aged Care: The Australian Health Care System: An Outline. Canberra, Department of Health &Aged Care, Sept 2000, Rep. No.: Publ Approval No. 2545.
9. Edmonds DJ, Dumbrell DM, Primrose JG, McManus P, Birkett DJ, Demirian V: Development of an Australian Drug Utilisation Database. Pharmacoeconomics 1993;3:427-432.
10. Robertson J, Fryer J, O'Connell DL, Smith AJ, Henry DA: Personal formularies: an index of prescribing quality? Eur J Clin Pharmacol 2001;57:333-341.
11. Trewin D: Information Paper: Census of Population and Housing Socio-Economic Indexes for Areas (SEIFA), 2001;ABS Catalogue No. 2039.0. ISBN 0-642-47936-4.
12. Oun A, Haldre S, Magi M: Prevalence of adult epilepsy in Estonia. Epilepsy Res 2003;52:233-242.
13. Keränen T, Riekkinen PJ, SillanpääM: Incidence and prevalence of epilepsy in adults in Eastern Finland. Epilepsia 1989;30:413-421.
14. Wright J, Pickard N, Whitfield A, Hakin N: A population-based study of the prevalence, clinical characteristics and effect of ethnicity in epilepsy. Seizure 2000;9:309-313.
15. MacDonald BK, Cockerell OC, Sander JWAS, Shorvon SD: The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain 2000;123:665-676.
16. Wallace H, Shorvon SD, Tallis R: Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet 1998;352:1970-1973.
17. Goodridge DMG, Shorvon SD: Epileptic seizures in a population of 6,000. Br Med J 1983;287:641-645.
18. Groves RM, Dillman DA, Eltinge JL, Little RJA: Survey Nonresponse. New York, Wiley, 2001.
19. Cockerell OC, Eckle I, Goodridge DMG, Sander JWAS, Shorvon SD: Epilepsy in a population of 6,000 re-examined: secular trends in first attendance rates, prevalence, and prognosis. J Neurol Neurosurg Psychiatry 1995;58:570-576.
20. Giuliani G, Terziani S, Senigaglia AR, Luccioni G, Foschi N, Maffer C: Epilepsy in an Italian community as assessed by a survey for prescriptions of antiepileptic drugs: epidemiology and patterns of care. Acta Neurol Scand 1992;85:23-31.
21. Rutgers MJ: Epilepsy in general practice: the Dutch situation. Epilepsia 1986;27:734-738.
22. Wang WZ, Wu JZ, Wang DS, Dai XY, Yang B, Wang TP, et al: The prevalence and treatment gap in epilpesy in China. Neurology 2003;60:1544-1545.
23. Coleman R, Loppy L, Walraven G: The treatment gap and primary health care for people with epilepsy in rural Gambia. Bull World Health Organ 2002;80:378-383.
24. Bharucha NE, Bharucha EP, Bharucha AE, Bhise AV, Schoenberg BS: Prevalence of epilepsy in the Parsi community of Bombay. Epilepsia 1988;29:111-115.
25. Olafsson E, Hauser WA: Prevalence of epilepsy in rural Iceland: a population-based study. Epilepsia 1999;40:1529-1534.
26. Beran RB, Hall L, Pesch A, Ho P, Lam S, Leung P-Y, et al: Population prevalence of epilepsy in Sydney, Australia. Neuroepidemiology 1982;1:201-208.
27. Zeilinski JJ: Epileptics not in treatment. Epilepsia 1974;15:203-210.
28. Haerer AF, Anderson DW, Schoenberg BS: Prevalence and clinical features of epilepsy in a biracial United States population. Epilepsia 1986;27:66-75.
29. Forsgren L: Prevalence of epilepsy in adults in Northern Sweden. Epilepsia 1992;33:450-458.
30. Da Mota Gomes M, Zeitoune RG, Kropf LAL, van Beeck EdS: A house-to-house survey of epileptic seizures in an urban community of Rio de Janeiro, Brazil. Arq Neuropsiquiatr 2002;60(3-B):708-711.
31. Rocca WA, Savettieri G, Anderson DW, Meneghini F, Grigoletto F, Morgante L, et al: Door-to-door prevalence survey of epilepsy in three Sicilian Municipalities. Neuroepidemiology 2001;20:237-241.
32. White PT, Buckley EG: The management of epilepsy - an audit of two practices. Health Bull (Edinb) 1981;39:82-88.
33. Sander JWAS, Shorvon SD: Epidemiology of the epilepsies. J Neurol Neurosurg Psychiatry 1996;61:433-443.
34. Maremmani C, Rossi G, Bonuccelli U, Murri L: Descriptive epidemiologic study of epilepsy syndromes in a district of Northwest Tuscany, Italy. Epilepsia 1991;32:294-298.
35. Birbeck GL, Kalichi EMN: Epilepsy prevalence in rural Zambia: a door-to-door survey. Trop Med Int Health 2004;9:92-95.
36. McCluggage JR, Ramsey HC, Irwin WG, Dowds MF: Anticonvulsant therapy in a general practice population in Northern Ireland. J R Coll Gen Pract 1986;34:24-31.
37. Lambie DG, Johnson RH, Stanaway L: Prescribing patterns for epilepsy. NZ Med J 1981;94:15-19.
38. De la Court A, Breteler MMB, Meinardi H, Hauser WA, Hofman A: Prevalence of epilepsy in the elderly. The Rotterdam Study. Epilepsia 1996;37:141-147.
39. Beghi E, Monticelli ML, Monza C, Sessa A, Zarrelli MM: Antiepileptic drugs as 'tracers' of disease. A calculation of the prevalence of epilepsy through an analysis of drug consumption. Neuroepidemiology 1991;10:33-41.
40. Drane JW: Imputing nonresponses to mailback questionnaires. Am J Epidemiol 1991;134:908-912.
41. Drane JW, Richter D, Stoskopf C: Improved imputation of non-responses to mailback questionnaires. Stat Med 1993;12:283-288.
42. Lammers MW, Hekster YA, Keyser A, Meinardi H, Renier WO, Herings RMC: Use of antiepileptic drugs in a community-dwelling Dutch population. Neurology 1996;46:62-67.